Huawei plans for more AI pharma tie-ups, says healthcare president

SHANGHAI, Aug 27 : Chinese technology conglomerate Huawei plans to expand its AI cooperation with local pharmaceutical firms into drug development and clinical practice, a senior executive said.The move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are investing in modelling tools and automated laboratories to shorten development timelines and improve efficiency."As we further deepen our research into AI in the medical field, we'll have more collaboration and results emerging with pharmaceutical companies from drug manufacturing to clinical to final implementation," William Zhang, president of Huawei's healthcare business unit, told Reuters on Wednesday.He said that Huawei had some existing collaborations in th